Hansa Medical Capital Markets Day in Stockholm,
November 13, 2015

Presentations

Introduction – Göran Arvidson, CE
The discovery of IdeS – Professor Lars Björck
IdeS scientific overview and indication landscape – Christian Kjellman, CSO
Addressable patient population for IdeS – Emanuel Björne, Corporate Development Director
Questions from moderator and audience
IdeS in transplantation – Professor S.Jordan
Rapid removal of anti-HLA antibodies in immunized patients awaiting renal transplantation – Professor Gunnar Tufveson
Treatment And Prevention of ABMR + Questions – Robert A. Montgomery
Route to registration
HBP-assay – Emanuel Björne
Our long term vision – Göran Arvidson

November 13, 2015
Wallenbergsalen, Kungliga Ingenjörsvetenskapsakademien, IVA
Grev Turegatan 16, Stockholm

Moderator: Mattias Häggblom

Program

8:30-9:00 Registration and coffee
9:00-9:10 Introduction – Göran Arvidson, CEO
9:10-9:30 The discovery of IdeS – Professor Lars Björck
9:30-9:50 IdeS scientific overview and indication landscape – Christian Kjellman, CSO
9:50-10:10 Addressable patient population for IdeS - Emanuel Björne, Corporate Development Director
10:10-10:30 Questions from moderator and audience
10:30-10:50 Coffee break
10:50-11:50 IdeS in transplantation – Dr. Tomas Lorant, Professor Stanley Jordan, and Professor Robert A. Montgomery
11:50-12:10 Questions from moderator and audience
12:10-12:45 Lunch
12:45-13:15 The route to registration – Ongoing and planned clinical trials, Lena Winstedt, Clinical Research Director, and Steven Glazer, CMO
13:15-13:30 Questions from moderator and audience
13:30-13:45 HBP-assay – Emanuel Björne
13:45-14:00 Our long term vision – Göran Arvidson

Speakers

Professor Lars Björck MD, PhD, Division of Infection Medicine at Lund University, collaborates with Hansa Medical through an extensive research contract engaging parts of his research team. IdeS was discovered through extensive research on Streptococcus pyogenes by Lars Björck and associates at Lund University.

Professor Stanley Jordan MD, PhD, is a Director of Kidney Transplantation and Transplant Immunology, Kidney and Pancreas Transplant Center and Director of Division of Pediatric and Adult Nephrology at Cedars Sinai Medical Center, Los Angeles, CA.

Professor Robert A. Montgomery, MD, DPhil, FACS is the Chief of the Division of Transplantation, Professor of Surgery, and the Director Comprehensive Transplant Center at Johns Hopkins, Baltimore, MD.

Dr. Tomas Lorant, MD, PhD, is Associate Professor, Department of Surgical Sciences, and Consultant Transplant Surgeon at Uppsala University Hospital. He is also principal investigator of the Hansa Medical phase II clinical study there.